The phase 3 STEER study enrolled 127 treatment-naïve patients aged 2 to less than 18 years with SMA type 2 who were able to sit but had never walked independently.
The researchers found that between 1999 and 2022, there were 63,550,429 deaths in the United States, of which 0.06% had cold recorded as an underlying or contributing cause of death. Cold-related ...
Health sector's share of the economy was similar in 2023 and 2022, but lower than in 2020 and 2021, during height of COVID-19 ...
(HealthDay News) — For adults with migraine, atogepant 60mg once daily was superior to placebo for efficacy and functional measures of treatment across 3 trials, according to research published online ...
The approval was based on data from the randomized, placebo-controlled, double-blind, phase 3 RATIONALE-305 trial.
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
(HealthDay News) — Higher daily step counts are associated with fewer depressive symptoms in adults, according to a systematic review and meta-analysis published online online December 16 in JAMA ...
(HealthDay News) — A high omega-3, low omega-6 diet with fish oil supplementation for one year results in a significant reduction of a marker of prostate cancer progression among men enrolled in ...
The Orphan Drug designation is based on data from the dose escalation phase of the open-label phase 1/2 study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback